The Future Fund: Breakthrough programme which was announced at Budget 2021 has now opened for applications.
The UK-wide programme will deliver £375m of government funding via British Patient Capital (a commercial subsidiary of the British Business Bank) who will make equity co-investments with private sector investors in later stage R&D-intensive UK companies operating in breakthrough technology sectors, such as cleantech and life sciences.
Further information, including full eligibility criteria for lead investors and companies is available here.